ImageneBio, Inc. (IMA)
About ImageneBio, Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $800.0K
- Net income
- -$45.3M
- Total assets
- $153.0M
- Market cap
- $63.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $63.1M
- Shares outstanding
- 14.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 28, 2025
ImageneBio, Inc. (IMA) Stock Price
- Reported a net loss of $45.3M in FY2025.
- Trading 52% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ImageneBio, Inc..
Write a review
News about ImageneBio, Inc.
News & sentiment via Polygon.io
ImageneBio, Inc.: frequently asked questions
Is ImageneBio, Inc. an American company?
ImageneBio, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is ImageneBio, Inc. headquartered?
ImageneBio, Inc. is headquartered in San Diego, California, United States.
Is ImageneBio, Inc. publicly traded?
Yes — ImageneBio, Inc. is a publicly traded company. Its stock trades under the ticker symbol IMA on the NASDAQ.
What does ImageneBio, Inc. do?
ImageneBio, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
